On July 29, 2026, the Federal Trade Commission filed a lawsuit against Hims & Hers Health in U.S. District Court for the Northern District of California. The states of California and Utah joined the case. The FTC’s complaint alleges that the telehealth company, which offers online prescriptions for conditions including erectile dysfunction, hair loss, weight loss, and mental health treatment, shared sensitive health data with Meta, Snap, and other third parties — despite telling customers their information would remain private.
The case has not yet concluded. Hims & Hers disputes the allegations and says the FTC disregarded evidence the company presented over three years of investigation. The company argues its privacy policy allows patients to choose how their data is used.
What the case makes visible is a mechanism that has been operating quietly inside health apps for years.
How Your Health Data Gets to Facebook
The specific mechanism alleged by the FTC involves tracking pixels — small pieces of code embedded in a website or app that report user behavior back to advertising platforms. Meta’s Pixel, Snap’s Pixel, and similar tools are standard tools in digital marketing, used by millions of websites to measure whether ads led to purchases, sign-ups, or page visits.
When these pixels are placed on health-related pages — intake forms, prescription checkout flows, specific condition pages — the data they collect can include information about which health conditions a user is researching, which prescriptions they’re seeking, and what personal details they provided during the intake process.
The FTC’s core allegation is that Hims & Hers had these pixels active on pages where patients disclosed sensitive health information, and that this data was transmitted to Meta and Snap while the company was simultaneously telling patients their data was protected.
Hims & Hers’ privacy policy, the company argues, disclosed that it uses third-party tracking technologies. But the FTC’s position is that buried disclosure language about “analytics partners” doesn’t constitute meaningful notice when users are disclosing information about their sexual health, mental health, or medical conditions.
Why This Isn’t Just About One Company
The behavior alleged against Hims & Hers is not unusual. The practice of using advertising pixels on healthcare-adjacent pages has been documented across a wide range of health, wellness, and telehealth companies.
A 2022 investigation by The Markup and STAT News found Meta’s tracking pixel on the websites of 33 of the 100 top US hospitals, including patient appointment portals. Subsequent research found similar patterns at telehealth companies, addiction treatment services, fertility clinics, and mental health platforms.
The FTC’s action against Hims & Hers is unusual not because of what the company allegedly did, but because a regulator is now explicitly treating this as a legal violation — specifically as an unfair or deceptive trade practice.
If the FTC prevails, it will establish a legal standard: that placing advertising pixels on health intake pages, while claiming your service is private, constitutes deception. That interpretation, if it sticks, has implications for every health app that has taken the same approach.
The HIPAA Gap
The United States’ primary federal health privacy law — HIPAA — applies to covered entities: hospitals, clinics, insurers, and their business associates. Direct-to-consumer telehealth companies and wellness apps often operate in a gap: they may handle deeply sensitive medical information while technically falling outside the scope of HIPAA’s strictest requirements.
This matters because HIPAA prohibits sharing patient health information with advertising platforms without explicit authorization. If Hims & Hers were a traditional healthcare provider, the conduct alleged by the FTC would almost certainly be a HIPAA violation. As a consumer telehealth company, the legal framework is less clear — which is part of why the FTC, rather than the Department of Health and Human Services, brought the case.
The FTC Act’s prohibition on unfair or deceptive trade practices is the legal vehicle being used here because the HIPAA framework may not cleanly reach the company’s conduct. That gap has been a subject of regulatory discussion for years, and cases like this one are part of an ongoing effort to establish norms in the absence of clear statutory rules.
What “Privacy Policy” Actually Means
One of the central tensions in the case involves what the words “your privacy is protected” mean when a company also uses advertising tracking on its intake forms.
Hims & Hers argues that its privacy policy disclosed its use of third-party technologies and gave users choices about how their data is used. The FTC argues that this framing doesn’t hold up: users seeking medical prescriptions are unlikely to read privacy policies carefully enough to understand that their health conditions will be transmitted to Facebook, and they’re in a situation where they have limited ability to opt out if they need the medication.
This gap — between technical disclosure in a privacy policy and meaningful user understanding — is at the heart of most consumer privacy litigation. A policy that says “we share data with analytics and advertising partners” in legal language doesn’t convey the same information as “we tell Facebook what health conditions you disclosed to us.”
The practical lesson for anyone evaluating a health app or telehealth service: the question isn’t whether the privacy policy exists, but what it actually permits. Apps that describe themselves as “private” or “confidential” while maintaining advertising infrastructure are using those words in a marketing sense, not in a technical one.
Reading a Health App’s Privacy Policy
Before trusting a health app with sensitive information, there are specific things worth checking:
Does the company use advertising or analytics pixels from Meta, Google, Snap, TikTok, or similar platforms? Check the platform’s cookie settings or look for mention of “third-party advertising partners” in the privacy policy. Many health apps will tell you plainly if you read the technical sections carefully.
What is the company’s business model? A service funded by advertising has structural incentives to maximize data collection and sharing. A service funded by subscriptions has structural incentives to keep the subscription worth paying for.
What does “we don’t sell your data” actually mean? Many privacy policies use this language while also stating that they “share” data with advertising partners for “measurement and analytics” purposes. These two things can coexist — sharing data with Meta for ad performance measurement is different from selling a list of names to a data broker, but both involve your health data leaving the app.
Has the company been subject to regulatory action or FTC investigation? This is public information. FTC complaints, state attorney general actions, and class action settlements are searchable. A three-year FTC investigation is not a minor compliance footnote.
Where Your Health Records Actually Belong
The Hims & Hers case draws attention to something worth thinking about more broadly: where you keep your personal health documentation.
Most people store health-related records across a loose collection of locations: email inboxes (prescription confirmation emails, appointment reminders), cloud storage (photos of prescription bottles, test result PDFs), and within apps themselves (health app data). None of these locations were chosen with health privacy specifically in mind.
An email inbox sits inside a service whose business model is advertising. A consumer cloud storage account may be bundled with AI features that scan and categorize content. An app’s internal storage is subject to that app’s data practices — which, as the Hims & Hers case demonstrates, may not align with what the company told you.
Keeping health records in a storage service whose sole business is storing your files — no ad tech, no data selling, no AI training on content — is a meaningfully different choice from keeping them in an email inbox or a general-purpose consumer cloud.
The Billing Allegations
The FTC’s complaint also covers subscription billing practices. The agency alleges that Hims & Hers charged customers for prescriptions almost immediately after they submitted intake forms, before a physician had reviewed their case, and that the cancellation process was deliberately difficult — a pattern the FTC describes as a “dark pattern.”
These billing allegations are separate from the data privacy claims but are part of the same enforcement action. The FTC’s framing positions data privacy violations and aggressive billing practices as two aspects of the same underlying consumer harm: a company prioritizing revenue over honest dealing with users.
What Comes Next
The case was filed in July 2026. As of November 2026, Hims & Hers has disputed the allegations. No ruling or settlement has been announced. If the case proceeds to judgment, it will either establish a binding legal standard for health app privacy practices or narrow the FTC’s ability to bring similar actions.
The case to watch: whether the court accepts the FTC’s argument that placing advertising pixels on health intake pages constitutes a deceptive trade practice regardless of what the privacy policy says. That question has implications for the entire direct-to-consumer health app industry.
In the meantime, the safest assumption is that apps collecting health information and operating advertising infrastructure are, in fact, using those two systems together — regardless of what their marketing says about privacy.